MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹11,907 Cr | ₹9,919 Cr | ₹8,012 Cr | ₹6,735 Cr | ₹5,304 Cr |
What is the latest Profit & Loss Account Balance ratio of MANKIND PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹11,907 Cr |
| Mar2024 | ₹9,919 Cr |
| Mar2023 | ₹8,012 Cr |
| Mar2022 | ₹6,735 Cr |
| Mar2021 | ₹5,304 Cr |
How is Profit & Loss Account Balance of MANKIND PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹11,907 Cr | 20.05 | |
| Mar2024 | ₹9,919 Cr | 23.80 | |
| Mar2023 | ₹8,012 Cr | 18.96 | |
| Mar2022 | ₹6,735 Cr | 26.99 | |
| Mar2021 | ₹5,304 Cr | - | |
Compare Profit & Loss Account Balance of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,310.3 Cr | -5% | -8.8% | -14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,287.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,657.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,202.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| CIPLA | ₹122,276.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,024.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -5% |
-8.8% |
-14.2% |
| SENSEX | -0.5% |
2% |
4.8% |
You may also like the below Video Courses